Family Medicine Doctors in Corning, AR Accepting Medicare
4 Family Medicine doctors found. Showing 1 - 4
 Dr. Shahid Saleem Shah, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 Creason Rd, Corning, AR 72422 Phone: 870-857-3399 Fax: 870-857-9934 |
Dr. Clinton Boone Smith, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 Creason Rd, Corning, AR 72422 Phone: 870-857-3399 Fax: 870-857-3301 |
Dr. Rickey L Mcgath, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 Creason Rd, Corning, AR 72422 Phone: 870-857-3399 Fax: 870-857-3301 |
Dr. Darrell L Hutchison, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 Creason Rd, Corning, AR 72422 Phone: 870-857-3399 Fax: 870-857-3301 |
News Archive
Lilly, Boehringer Ingelheim receive FDA approval for Tradjenta sNDA to treat type 2 diabetes
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Tradjenta (linagliptin) tablets for use as add-on therapy to insulin.
A paper-based sensor for detecting COVID-19
News-Medical talks to Dipanjan Pan about the development of a paper-based electrochemical sensor that can detect COVID-19 in less than five minutes.
Former U.N. Secretary-General, Gates Foundation CEO, Ethiopian official address World Food Prize conference
In a speech at the World Food Prize conference on Thursday, former U.N. Secretary-General Kofi Annan discussed several topics related to food security and said that discrimination against women is limiting agricultural development in Africa, the Des Moines Register reports.
Cell Therapeutics receives FDA Complete Response Letter for Pixuvri NDA
Cell Therapeutics, Inc. today announced that it had received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for Pixuvri™ (pixantrone dimaleate) for relapsed or refractory aggressive non-Hodgkin's lymphoma ("NHL").
Gene therapy is key to addressing Sanfilippo Syndrome, say Ohio scientists and clinicians
Gene therapy is the delivery of DNA into a patient's cells to replace faulty or missing genes—or adds new genes—in an attempt to cure cancer or make changes so the body is better able to fight off disease. Scientists and clinicians have identified a number of different ways to do this, in an effort to correct malfunctioning or mutated genes. Many gene therapy clinical trials are ongoing to assess the safety and potential benefits in patients with rare diseases.
› Verified 7 days ago